BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1119396)

  • 21. The left ventricular systolic function after digoxin administration in patients with chronic renal failure.
    Trznadel K; Luciak M; Wyszogrodzka M
    Clin Nephrol; 1980 May; 13(5):231-4. PubMed ID: 7398145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Favorable effects of oral digoxin therapy on the left ventricular performance in patients with artificial pacemakers.
    Saito K; Tanaka H; Kashima T; Katanasako H; Okamoto M; Kanehisa T
    Eur J Cardiol; 1980; 12(1):1-13. PubMed ID: 7439229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digoxin therapy and left ventricular performance in premature infants with patent ductus arteriosus.
    Lundell BP; Boréus LO
    Acta Paediatr Scand; 1983 May; 72(3):339-43. PubMed ID: 6880719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Plasma-digoxin concentrations after an intravenous loading dose.
    Bertler A; Bergdahl B; Karlsson E
    Lancet; 1974 Oct; 2(7886):958. PubMed ID: 4138368
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacodynamic and pharmacokinetic approaches to optimization of the use of digoxin in the subacute period of myocardial infarction in late middle-age and elderly patients].
    Iakovlev SV; Glezer MG; Kholodov LE; Chistova VS; Mikhaĭlov AA
    Kardiologiia; 1986 Sep; 26(9):92-5. PubMed ID: 3784274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure.
    Harjola VP; Oikarinen L; Toivonen L; Jurkko R; Puttonen J; Sarapohja T; Sundberg S; Nieminen MS
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):389-99. PubMed ID: 18793580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.
    Okada RD; Hager WD; Graves PE; Mayersohn M; Perrier DG; Marcus FI
    Circulation; 1978 Dec; 58(6):1196-203. PubMed ID: 709776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the problem of optimum digitlaization in man.
    Lampe D; Lampe H; Berwing K; Parsi RA; Mai I
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):380-3. PubMed ID: 689798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a simplified nomogram to individualize digoxin dosing versus standard dosing practices in patients with heart failure.
    DiDomenico RJ; Bress AP; Na-Thalang K; Tsao YY; Groo VL; Deyo KL; Patel SR; Bishop JR; Bauman JL
    Pharmacotherapy; 2014 Nov; 34(11):1121-31. PubMed ID: 25164709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum digoxin by radioimmunoassay.
    Hoeschen RJ; Proveda V
    Can Med Assoc J; 1971 Jul; 105(2):170-3. PubMed ID: 5104858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of digoxin absorption and relation of serum levels to cardiac arrhythmias in children.
    Larese RJ; Mirkin BL
    Clin Pharmacol Ther; 1974 Apr; 15(4):387-96. PubMed ID: 4821442
    [No Abstract]   [Full Text] [Related]  

  • 32. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of long-term administration of 3H-digoxin to the pregnant ewe upon the cardiovascular hemodynamics of the fetal lamb.
    Hernandez A; Strauss A; Burton RM; Goldring D
    Am J Obstet Gynecol; 1975 Apr; 121(8):1100-2. PubMed ID: 1168022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetic and cardiac efficacy of beta-acetyldigoxin and digitoxin in combination therapy with diltiazem].
    Kuhlmann J; Marcin S
    Klin Wochenschr; 1985 Jul; 63(14):636-42. PubMed ID: 4032988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The physiologic effects of digoxin under steady-state drug conditions in newborn and adult sheep.
    Berman W; Musselman J; Shortencarrier R
    Circulation; 1980 Dec; 62(6):1165-71. PubMed ID: 7438352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of digoxin on ejection fraction in elderly patients with congestive heart failure.
    Ware JA; Snow E; Luchi JM; Luchi RJ
    J Am Geriatr Soc; 1984 Sep; 32(9):631-5. PubMed ID: 6236251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac effects of treatment with quinidine and digoxin, alone and in combination.
    Schenck-Gustafsson K; Jogestrand T; Brodin LA; Nordlander R; Dahlqvist R
    Am J Cardiol; 1983 Mar; 51(5):777-82. PubMed ID: 6829437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of digoxin on the extent of injury and the severity of arrhythmias during acute myocardial ischemia and infarction in the dog.
    Lynch JJ; Lucchesi BR
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):193-203. PubMed ID: 2452314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-dependent shortening of systolic time intervals after intake of pengitoxin.
    Haustein KO; Hentschel H
    Int J Clin Pharmacol Res; 1987; 7(1):19-25. PubMed ID: 3583485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.